By Sam Sather,Signant Health, formerly CRF Bracket
Electronic informed consent, or eConsent, is one technological advancement introduced to clinical trials that is escalating in its adoption. In this blog, get five tips for implementing and preparing for eConsent.
Ensuring your material is stored under appropriate conditions is only half the battle in preserving its integrity. Equally as critical is the precarious process of transporting your material to its destination, safely and in the same condition it was sent in. Maintaining the chain of custody is of utmost importance, and a large component of this is based on the vessel selected for transportation. In this article, we’ll share some key items to consider when selecting shippers to transport your high-value material.
Late-phase research in the life sciences segment is undergoing a rapid transformation due to the digitalization of healthcare and the greater availability of, and access to, real world data (RWD). This transformation is arriving not a moment too soon, given the changes anticipated from the Twenty-First Century Cures Act, EMA’s Adaptive Pathways approach, and the increased demand for real-world evidence (RWE) generated from RWD. In addition to supporting regulatory decisions, RWE is playing an ever-expanding role in developing the product value propositions that are driving reimbursement decisions globally.
Patient centricity isn’t just a buzzword. It’s the key to achieving a sustainable clinical trial paradigm that reduces the burden of participation and accelerates drug development — especially in rare disease research. Watch this video to learn how to make clinical trials more successful and patient-focused.